Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2008 -28.48M
June 30, 2008 -32.61M
March 31, 2008 -31.58M
December 31, 2007 -42.70M
September 30, 2007 -41.32M
June 30, 2007 -38.82M
March 31, 2007 -47.16M
December 31, 2006 -49.18M
September 30, 2006 -49.85M
June 30, 2006 -61.22M
March 31, 2006 -60.95M
December 31, 2005 -63.66M
Date Value
September 30, 2005 -64.49M
June 30, 2005 -49.15M
March 31, 2005 -39.84M
December 31, 2004 -31.50M
September 30, 2004 -24.85M
June 30, 2004 -24.16M
March 31, 2004 -19.97M
December 31, 2003 -16.04M
September 30, 2003 -15.38M
June 30, 2003 -16.18M
March 31, 2003 -16.29M
December 31, 2002 -18.37M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 167.52M
Corcept Therapeutics, Inc. 106.92M
Veru, Inc. -26.04M
Johnson & Johnson 22.61B
Eli Lilly & Co. 13.56B